Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jul-Aug;31(4):530-9.
doi: 10.1177/0272989X11408730. Epub 2011 Jun 14.

A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression

Affiliations
Comparative Study

A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression

Karen M Kuntz et al. Med Decis Making. 2011 Jul-Aug.

Abstract

Background: As the complexity of microsimulation models increases, concerns about model transparency are heightened.

Methods: The authors conducted model "experiments" to explore the impact of variations in "deep" model parameters using 3 colorectal cancer (CRC) models. All natural history models were calibrated to match observed data on adenoma prevalence and cancer incidence but varied in their underlying specification of the adenocarcinoma process. The authors projected CRC incidence among individuals with an underlying adenoma or preclinical cancer v. those without any underlying condition and examined the impact of removing adenomas. They calculated the percentage of simulated CRC cases arising from adenomas that developed within 10 or 20 years prior to cancer diagnosis and estimated dwell time-defined as the time from the development of an adenoma to symptom-detected cancer in the absence of screening among individuals with a CRC diagnosis.

Results: The 20-year CRC incidence among 55-year-old individuals with an adenoma or preclinical cancer was 7 to 75 times greater than in the condition-free group. The removal of all adenomas among the subgroup with an underlying adenoma or cancer resulted in a reduction of 30% to 89% in cumulative incidence. Among CRCs diagnosed at age 65 years, the proportion arising from adenomas formed within 10 years ranged between 4% and 67%. The mean dwell time varied from 10.6 to 25.8 years.

Conclusions: Models that all match observed data on adenoma prevalence and cancer incidence can produce quite different dwell times and very different answers with respect to the effectiveness of interventions. When conducting applied analyses to inform policy, using multiple models provides a sensitivity analysis on key (unobserved) "deep" model parameters and can provide guidance about specific areas in need of additional research and validation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graphical representation of natural history of colorectal disease.
Figure 2
Figure 2
Comparison of natural history models with respect to adenoma prevalence (proportion of population with adenomas by age; Panel A) and colorectal cancer incidence (number of cases per 100,000 by age; Panel B). Autopsy data points are represented by “×” in Panel A. Surveillance, Epidemiology, and End-Results (SEER) Program data from 1975-1979 were used to represent colorectal cancer incidence in an unscreened population.
Figure 2
Figure 2
Comparison of natural history models with respect to adenoma prevalence (proportion of population with adenomas by age; Panel A) and colorectal cancer incidence (number of cases per 100,000 by age; Panel B). Autopsy data points are represented by “×” in Panel A. Surveillance, Epidemiology, and End-Results (SEER) Program data from 1975-1979 were used to represent colorectal cancer incidence in an unscreened population.
Figure 3
Figure 3
Cumulative colorectal cancer incidence for two subgroups of a 55-year-old cohort of cancer-free individuals: (1) individuals initially without a lesion (either adenoma or preclinical cancer) and (2) individuals with a lesion (adenoma or preclinical cancer but not removed or treated).
Figure 4
Figure 4
Cumulative colorectal cancer incidence for a cancer-free 55-year-old cohort with untreated lesions (either adenoma or preclinical cancer) vs. the same cohort with all adenomas removed via polypectomy and all preclinical cancers detected.

Comment in

References

    1. American Cancer Society . Cancer Facts & Figures 2010. American Cancer Society; Atlanta: 2010.
    1. Morson BC. The pathogenesis of colorectal cancer. Introduction. Major Probl Pathol. 1978;10:1–13. - PubMed
    1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–60. - PubMed
    1. U.S. Preventive Services Task Force Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37. - PubMed
    1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71. - PubMed

Publication types